Cargando…

A big STEP (Simultaneous Tumor and Effector Profiling) forward in the battle against chimeric antigen receptor (CAR) T-cell therapy resistance

Detalles Bibliográficos
Autores principales: Sondhi, Anya K., Risso, Carla Barrientos, Taylor, Justin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643940/
https://www.ncbi.nlm.nih.gov/pubmed/37969398
http://dx.doi.org/10.21037/tcr-23-1247
_version_ 1785147176815427584
author Sondhi, Anya K.
Risso, Carla Barrientos
Taylor, Justin
author_facet Sondhi, Anya K.
Risso, Carla Barrientos
Taylor, Justin
author_sort Sondhi, Anya K.
collection PubMed
description
format Online
Article
Text
id pubmed-10643940
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-106439402023-11-15 A big STEP (Simultaneous Tumor and Effector Profiling) forward in the battle against chimeric antigen receptor (CAR) T-cell therapy resistance Sondhi, Anya K. Risso, Carla Barrientos Taylor, Justin Transl Cancer Res Editorial Commentary AME Publishing Company 2023-10-10 2023-10-31 /pmc/articles/PMC10643940/ /pubmed/37969398 http://dx.doi.org/10.21037/tcr-23-1247 Text en 2023 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Editorial Commentary
Sondhi, Anya K.
Risso, Carla Barrientos
Taylor, Justin
A big STEP (Simultaneous Tumor and Effector Profiling) forward in the battle against chimeric antigen receptor (CAR) T-cell therapy resistance
title A big STEP (Simultaneous Tumor and Effector Profiling) forward in the battle against chimeric antigen receptor (CAR) T-cell therapy resistance
title_full A big STEP (Simultaneous Tumor and Effector Profiling) forward in the battle against chimeric antigen receptor (CAR) T-cell therapy resistance
title_fullStr A big STEP (Simultaneous Tumor and Effector Profiling) forward in the battle against chimeric antigen receptor (CAR) T-cell therapy resistance
title_full_unstemmed A big STEP (Simultaneous Tumor and Effector Profiling) forward in the battle against chimeric antigen receptor (CAR) T-cell therapy resistance
title_short A big STEP (Simultaneous Tumor and Effector Profiling) forward in the battle against chimeric antigen receptor (CAR) T-cell therapy resistance
title_sort big step (simultaneous tumor and effector profiling) forward in the battle against chimeric antigen receptor (car) t-cell therapy resistance
topic Editorial Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643940/
https://www.ncbi.nlm.nih.gov/pubmed/37969398
http://dx.doi.org/10.21037/tcr-23-1247
work_keys_str_mv AT sondhianyak abigstepsimultaneoustumorandeffectorprofilingforwardinthebattleagainstchimericantigenreceptorcartcelltherapyresistance
AT rissocarlabarrientos abigstepsimultaneoustumorandeffectorprofilingforwardinthebattleagainstchimericantigenreceptorcartcelltherapyresistance
AT taylorjustin abigstepsimultaneoustumorandeffectorprofilingforwardinthebattleagainstchimericantigenreceptorcartcelltherapyresistance
AT sondhianyak bigstepsimultaneoustumorandeffectorprofilingforwardinthebattleagainstchimericantigenreceptorcartcelltherapyresistance
AT rissocarlabarrientos bigstepsimultaneoustumorandeffectorprofilingforwardinthebattleagainstchimericantigenreceptorcartcelltherapyresistance
AT taylorjustin bigstepsimultaneoustumorandeffectorprofilingforwardinthebattleagainstchimericantigenreceptorcartcelltherapyresistance